Replies to post #65580 on Anavex Life Sciences Corp (AVXL)

[JB3729]

That was the author's share price target in August, 2015. That was before the full top line 5 week data was released in November, 2015.

From pre-split August, 2015 article -

In AD alone, AVXL has a fair value of $5 per share, after adjusting for risk. If you add the potential in Parkinson's, then the potential value of the stock is even higher. If AVXL's concept is proven in AD, it is very likely that it will be proven in Parkinson's as well.

http://seekingalpha.com/article/3444196-premarket-biotech-digest-axovant-analysis-anavex-gets-grant-pharmacyclis-imbruvica?auth_param=btpbb:1at3j0l:afa85ef47d3b60d78c9840325c93132b&uprof=45

[Homework.Investwell]

A 10B market cap would be low!!!

With 35.71M shares outstanding 10B is $280pps.....and IMO AVXL will be valued up from there unless great news soon with an early buyout offer of 5-10B! I'm certainly not opposed to that! We'll know a lot more by the end of July-Aug. Stayed tuned with patience. May even have another good swing trade coming to take some profits? ;)